126,15 <%= Resources.Global.txtDown %>
Opdateret 10:21:13
Ændring % -0,04% Fald i aktiekurs
Ændring -0,05 Fald i aktiekurs
Volume 12.981
Høj 127,00
Lav 125,60
Åben 126,50
ISIN FR0010259150
Seneste luk 126,20
# af aktier 83,79M
Markedsværdi 10.571M EUR
I dag

Ipsen
Markedet er åbent (indtil 17:30) - Forsinket 15 min
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  126,15 1,0% Stigning i aktiekurs -11,9% Fald i aktiekurs -11,9% Fald i aktiekurs -0,9% Fald i aktiekurs 9,3% Stigning i aktiekurs
Powered by TradingView

Firmaprofil

Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focuses on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Berlingske Media 2018  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. oktober 2018 11:30:31
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20181021.1 - EUROWEB6 - 2018-10-22 11:30:31 - 2018-10-22 11:30:31 - 1 - Website: OKAY